Buy or sell Viome stock pre IPO via an EquityZen fund
Discovering predictive biomarkers to eradicate all diseases.
About Viome Stock
Viome is a team of leading entrepreneurs, scientists, and physicians. Their proven expertise is why Viome is the only private company trusted with exclusive license to technology first developed at the prestigious Los Alamos National Laboratory. Viome’s pioneering artificial learning engines are designed to not only analyze your data, but to aggregate all the biological data they receive. As the sample size grows, their machines will spot trends and influences, which will unlock scientific breakthroughs.
Founder & President
Founder & CEO
Chief Medical Officer
SFGate - Jun, 4 2018
MobiHealthNews - Aug, 7 2017
The Seattle Times - Jul, 31 2017
Forbes - Jul, 5 2018